Where is Vyuhaa Med Data headquartered?

Vyuhaa Med Data is headquartered in Hyderabad, Telangana, India. The company has a team of 11-50 people.

What does Vyuhaa Med Data do?

Vyuhaa Med Data operates in the AI in Healthcare sector. A deep-tech startup developing AI-powered digital pathology and edge-computing diagnostic solutions for healthcare and agriculture. Delivers affordable, real-time diagnostic accuracy at the point of care by combining proprietary deep learning models with low-cost edge hardware, bypassing the need for expensive lab infrastructure.

When was Vyuhaa Med Data founded?

Vyuhaa Med Data was founded in 2022. It is based in Hyderabad, Telangana, India.

Who is the CEO of Vyuhaa Med Data?

Dhritiman Mallick is the CEO of Vyuhaa Med Data. The company was founded in 2022.

Where is Vyuhaa Med Data located?

Vyuhaa Med Data is headquartered in Hyderabad, Telangana, India.

What funding stage is Vyuhaa Med Data at?

Vyuhaa Med Data is currently at the Early Stage stage.

How many employees does Vyuhaa Med Data have?

Vyuhaa Med Data has approximately 11-50 employees.

Vyuhaa Med Data

Category: AI in Healthcare

A deep-tech startup developing AI-powered digital pathology and edge-computing diagnostic solutions for healthcare and agriculture. Vyuhaa Med Data was founded in 2022. The company is led by Dhritiman Mallick. Based in Hyderabad, Telangana, India. Team size: 11-50. Total funding raised: $150K. Latest round: Seed. Key investors include C-CAMP, MeitY Startup Hub, iTNT Hub, MIT Solve, NVIDIA Inception Program, Bio Valley Incubation Council.

Founded: 2022
Headquarters: Hyderabad, Telangana, India
Team size: 11-50
Total funding: $150K

Value proposition

Delivers affordable, real-time diagnostic accuracy at the point of care by combining proprietary deep learning models with low-cost edge hardware, bypassing the need for expensive lab infrastructure.

Products and solutions

CerviAI: AI-powered cervical cancer screening platform for low-cost diagnostics., AI-Powered Microscope: Automated disease detection system for silkworms (Pebrine disease)., Edge-AI Digital Pathology Platform: Software for real-time medical image analysis., Automated Disease Detection Software: General-purpose AI models for microscopic analysis.

Unique value

Successfully repurposes high-end medical AI (digital pathology) to solve niche agricultural problems, such as reducing crop loss for silk farmers through automated microscopic screening.

Target customer

Healthcare providers (rural and urban), diagnostic laboratories, government agricultural departments, and silk farmers.

Industries served

Healthcare AI, Agri-Tech (Sericulture), Digital Pathology, Edge Computing

Technology advantage

Proprietary deep learning algorithms optimized for edge devices, enabling high-speed image processing and diagnosis in remote areas without reliance on cloud connectivity or expensive laboratory hardware.

How they differentiate

Vyuhaa differentiates through 'Edge-AI' capabilities, allowing high-speed diagnostic processing locally on the device without requiring cloud connectivity. Unlike competitors focused solely on clinical settings, Vyuhaa has successfully adapted its medical-grade AI microscopy for agricultural use (sericulture), creating a unique dual-market revenue model.

Main competitors

SigTuple, Periwinkle Technologies, Karkinos Healthcare

Key partnerships

C-CAMP, MeitY Startup Hub / IndiaAI, Bio Valley Incubation Council (AMTZ), ICMR (clinical validation), National Cancer Grid (NCG CATCH Grant), NVIDIA Inception, iTNT Hub, MIT Solve (2024 Global Health Equity Challenge), Hamamatsu Photonics

Notable customers

CPath Labs, Fernandez Hospitals, Government of Tamil Nadu (iTNT Hub), NCG-partner cancer hospitals (e.g. Homi Bhabha Cancer Hospital network per IndiaAI/NCG), Diagnostic laboratories in South India

Major milestones

Winner of the iTNT Innovation Challenge 2023, MIT Solve 2024 Global Health Equity Challenge (CerviAI), Commercial launch of CerviAI for cervical cancer screening, Seed funding $150K (Jan 2026) from C-CAMP / MeitY Startup Hub, IndiaAI–NCG CATCH Grant awardee 2026 for CerviAI, Incubated at Bio Valley Incubation Council (AMTZ), Invest Karnataka VentuRise recognition; Top NVIDIA Inception startup in India

Growth metrics

Raised $150K Seed (Jan 2026); NCG CATCH Grant awardee 2026; ~15–16 employees (Inc42/Tracxn mid-2026); deployed in 3 Indian states + international pilot; 10,000+ women screened (IIMB alumni account, 2025); NVIDIA Inception / MeitY / ICMR / Bio Valley backed.

Market positioning

Early-stage deep-tech innovator specializing in affordable, point-of-care diagnostic hardware and software for resource-constrained environments.

Geographic focus

Primary focus on India (Rural and Semi-urban), with expansion targets in Southeast Asia and Sub-Saharan Africa through global health partnerships.

Patents and IP

Proprietary AI models and diagnostic algorithms; specific registered patents not publicly disclosed as of latest update.

About Dhritiman Mallick

Dhritiman Mallick is Co-founder & CEO of Vyuhaa Med Data (since Jan 2024). IIM Bangalore PGP 2016 alumnus; previously Client Engagement Manager at Monitor Deloitte (~6 years) with a global consulting career across the US, Japan, and China, and earlier roles including State Bank of India. Focuses on AI-native cancer diagnostics and last-mile women's health screening.

Latest news about Vyuhaa Med Data

Vyuhaa Med Data is scaling its AI-assisted digital microscopy platform from India to South Korea as a Top 40 finalist in the K-Startup Grand Challenge 2025. Leveraging a databank of 100,000+ cytology

More AI in Healthcare companies

Official website: https://vyuhaadata.com/